Drug-Induced Phospholipidosis: Are There Functional Consequences?
Open Access
- 1 October 2001
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 226 (9), 825-830
- https://doi.org/10.1177/153537020122600903
Abstract
Phospholipidosis induced by drugs with a cationic amphiphilic structure is a generalized condition in humans and animals that is characterized by an intracellular accumulation of phospholipids and the concurrent development of concentric lamellar bodies. The primary mechanism responsible for the development of phospholipidosis is an inhibition of lysosomal phospholipase activity by the drugs. While the biochemical and ultrastructural features of the condition have been well characterized, much less effort has been directed toward understanding whether the condition has adverse effects on the organism. While there are a few cationic amphiphilic drugs that have been reported to cause phospholipidosis in humans, the principal concern with this condition is in the pharmaceutical industry during preclinical testing. While this class of drugs should technically be referred to as cationic lipophilic, the term cationic amphiphilic is widely used and recognized in this field, and for this reason, the terminology cationic amphiphilic drugs (CADs) will be employed in this Minireview. The aim of this Minireview is to provide an evaluation of the state of knowledge on the functional consequences of CAD-induced phospholipidosis.Keywords
This publication has 53 references indexed in Scilit:
- Gentamicin nephrotoxicity in humans and animals: Some recent researchGeneral Pharmacology: The Vascular System, 1995
- Pathogenic factors in aminoglycoside-induced nephrotoxicityToxicology Letters, 1990
- Disobutamide: A model agent for investigating intracellular drug storageToxicology and Applied Pharmacology, 1989
- Mrphological and Functional Changes in Mouse Splenic Lymphocytes Followingin Vivoand inVitroExposure to ChlorphentermineImmunopharmacology and Immunotoxicology, 1986
- Amiodarone Hepatotoxicity Simulating Alcoholic Liver DiseaseNew England Journal of Medicine, 1984
- Alterations in newborn and adult rat lung morphology and phospholipid levels after chlorcyclizine or chlorphentermine treatmentToxicology and Applied Pharmacology, 1982
- Alveolar Macrophage Mediated Pulmonary Clearance Suppressed by Drug-Induced PhospholipidosisExperimental Lung Research, 1982
- Biochemical and morphologic investigation of the influence of chlorphentermine and subsequent withdrawal on newborn rat lungToxicology and Applied Pharmacology, 1979
- Effect of chlorphentermine on the lipids of rat lungs.Thorax, 1976
- Drug-Induced Foam Cell Reactions in Rats, II. Chemical Analysis of Lipids Stored in Lungs and Foam Cells after Treatment with Chlorphentermine, 5-[p-(Fluoren-9-ylidenemethyl)phenyl]-2-piperidineethanol (RMI 10.393) and 1-ChloramitriptylineHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1975